Reshoring, AI construction, and a chemical boom just collided with the tightest railcar market in 15 years.
Month: July 2026
Eli Lilly Is Down From Its High. Its Business Has Never Been Stronger.
Q1 revenue grew 56% and Mounjaro just became the world’s best-selling drug.
The AI Thermal Crisis Nobody Is Pricing Correctly
Every hyperscale AI factory has a heat problem. One mid-cap company just signed a $4 billion contract to solve it.
Meta Is Down About 16% From Its 52-Week High. July 22 Is the Number That Matters.
A $125B–$145B capex bet, 33% revenue growth, and a stock trading well below its peak heading into Q2 earnings.
IWM’s Best First Half Since 1991. Now Someone Bet $20M It Gets Messy.
The small-cap rotation trade is real. But the options market just flagged something worth watching.
Arm Is Up 11% Today. The Real Debate Starts July 29.
A $100 billion market thesis meets the most stretched valuation in semiconductors.
Opendoor Is Up 11% While the Bears Are Still Publishing
A short seller fired. The market shrugged. July 30 is where this gets resolved.
Lockheed Martin Just Got a $35 Billion Head Start on a War Nobody Priced Correctly
The ceasefire collapsed this morning. The THAAD backlog didn't.
Alibaba Is Up 11%. The Real Story Starts in August.
A pre-earnings briefing just rewrote the investment case for China's most beaten-down mega-cap.
Gilead Trades at 13x. AbbVie Just Raised Guidance Again. One Is Priced Wrong.
Two biopharma giants sitting at opposite ends of the market's attention span.